Innate-like T cell lineages contribute to host defense against pathogens at mucosal barriers. However, there is a fundamental gap that separates the clinicopathologic relevance of their powerful effector properties from a molecular understanding of their regulation. The major questions arise from the surprising observation that the innate-like effector program is acquired during thymic development, independently of microbial exposure, rather than upon encounter with pathogens. The research has crystallized around the recent finding that the innate-like effector program is directed by a novel transcription factor, promyelocytic leukemia zinc factor (PLZF), which is also responsible for a subset of human leukemias. The long-term goal of these studies is to understand in molecular details the development and the functional program of innate-like T cells. The objective of this application is to define the mechanisms by which PLZF enables the effector properties of innate-like T cells. Our central hypothesis is that PLZF directly or indirectly regulates critical transcription factors that separately or together activate different arms of this effector program. The rationale for thi project is that it will provide unprecedented insight into the molecular interactions that regulate the differentiation of effector programs and, in turn, will allow manipulation of these processes for therapeutic benefit. The proposed hypothesis will be tested by pursuing the following specific aims: 1) to characterize the target genes bound by PLZF, and the resulting changes in epigenetic marks and transcriptional program;2) to characterize the specific role of key transcription factors in differentiating the effector program. While each aim focuses on different approaches, the data will be integrated to develop a model of the transcriptional network regulating the innate-like effector program. The proposal is innovative because it explores the novel idea that a master transcription factor directs the innate-like effector program, which would signal a major shift in our understanding of the biology of innate-like effector T cells. The proposed research is significant because it will enhance our understanding of lymphocyte effector programs and link specific transcription factors to different arms of this program. The concepts and tools developed will make it possible to develop agents that target distinct components of effector programs and, ultimately, to enhance immunity to a range of microbial pathogens.

Public Health Relevance

The proposed research will provide a molecular understanding of the mechanisms that control the early phase of immune responses to microbial organisms at mucosal barriers. It is relevant to public health because discovery of these mechanisms allow development of means or agents to prevent or correct defects in disease and to enhance immunity to pathogens. Thus, this work will directly support the overall NIH mission of developing fundamental knowledge that will help reduce the burden of human disease and promote the NIAID goals of improving immunity to infection and eradicating infectious diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI038339-17A1
Application #
8578298
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Miller, Lara R
Project Start
1996-04-15
Project End
2017-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
17
Fiscal Year
2013
Total Cost
$420,226
Indirect Cost
$151,823
Name
University of Chicago
Department
Pathology
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Mao, Ai-Ping; Constantinides, Michael G; Mathew, Rebecca et al. (2016) Multiple layers of transcriptional regulation by PLZF in NKT-cell development. Proc Natl Acad Sci U S A 113:7602-7
Verhoef, Philip A; Constantinides, Michael G; McDonald, Benjamin D et al. (2016) Intrinsic functional defects of type 2 innate lymphoid cells impair innate allergic inflammation in promyelocytic leukemia zinc finger (PLZF)-deficient mice. J Allergy Clin Immunol 137:591-600.e1
Ishizuka, Isabel E; Chea, Sylvestre; Gudjonson, Herman et al. (2016) Single-cell analysis defines the divergence between the innate lymphoid cell lineage and lymphoid tissue-inducer cell lineage. Nat Immunol 17:269-76
Bunker, Jeffrey J; Flynn, Theodore M; Koval, Jason C et al. (2015) Innate and Adaptive Humoral Responses Coat Distinct Commensal Bacteria with Immunoglobulin A. Immunity 43:541-53
Constantinides, Michael G; Gudjonson, Herman; McDonald, Benjamin D et al. (2015) PLZF expression maps the early stages of ILC1 lineage development. Proc Natl Acad Sci U S A 112:5123-8
McDonald, Benjamin D; Bunker, Jeffrey J; Erickson, Steven A et al. (2015) Crossreactive αβ T Cell Receptors Are the Predominant Targets of Thymocyte Negative Selection. Immunity 43:859-69
McDonald, Benjamin D; Bunker, Jeffrey J; Ishizuka, Isabel E et al. (2014) Elevated T cell receptor signaling identifies a thymic precursor to the TCRαβ(+)CD4(-)CD8β(-) intraepithelial lymphocyte lineage. Immunity 41:219-29
Constantinides, Michael G; McDonald, Benjamin D; Verhoef, Philip A et al. (2014) A committed precursor to innate lymphoid cells. Nature 508:397-401
Mathew, Rebecca; Mao, Ai-ping; Chiang, Andrew H et al. (2014) A negative feedback loop mediated by the Bcl6-cullin 3 complex limits Tfh cell differentiation. J Exp Med 211:1137-51
Luoma, Adrienne M; Castro, Caitlin D; Mayassi, Toufic et al. (2013) Crystal structure of Vδ1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human γδ T cells. Immunity 39:1032-42

Showing the most recent 10 out of 43 publications